|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General, administrative and other | |||
| Total operating expenses | |||
| Loss from operations | |||
| Change in fair value of liability instrument | |||
| Other income/(expense): | |||
| Change in fair value of warrant liability | |||
| Change in fair value of forward contract liability | |||
| Change in fair value of SEPA put option liability | |||
| Change in fair value of convertible debt | |||
| Commitment fee expenses | |||
| Placement agent and tail fee expenses | |||
| Other income/(expense) | |||
| Gain on termination of warrant and commitment fee liabilities | |||
| Interest income | |||
| Interest expense | |||
| Total other income/(expense) | |||
| Net loss | |||
| Deemed dividend | |||
| Net loss attributable to common stockholders | |||
| Net loss per share, basic | |||
| Net loss per share, diluted | |||
| Weighted-average shares outstanding, basic | |||
| Weighted-average shares outstanding, diluted |
Loading...
